Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis

NCT00622908 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: ISV-403
DRUG: Vehicle

Sponsor

Bausch & Lomb Incorporated